FibroBiologics, Inc. (FBLG) earnings
FBLG earnings moved a median of +1.82% by the close. Quarterly and annual FBLG reports and results, each read against the price at its own news timestamp. Back to the FBLG overview →
19 measured FBLG earnings events.
Where these FBLG earnings landedvs 19 measured FBLG earnings reactions
| Middle 50% of FBLG earnings reactions | -4.99% to +6.54% |
|---|---|
| Median reaction (to close) | +1.82% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 FBLG earnings events with a measured close landed between -4.99% and +6.54%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate | Press release | +2.78% | +9.79% | |
| Form 10-Q FibroBiologics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.78% | +9.79% | |
| Form 10-Q FibroBiologics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.10% | +13.18% | |
| Form 10-K/A FibroBiologics, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.21% | -12.61% | |
| Form 10-K FibroBiologics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.19% | +1.86% | |
| FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +2.75% | +3.30% | |
| Form 10-Q FibroBiologics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.75% | +3.30% | |
| FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -1.10% | +1.82% | |
| Form 10-Q FibroBiologics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.10% | +1.82% | |
| FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | -0.80% | +24.91% | |
| Form 10-Q FibroBiologics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.80% | +24.91% | |
| Form 10-K FibroBiologics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.10% | -9.47% | |
| FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +9.31% | -2.84% | |
| Form 10-Q FibroBiologics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +9.31% | -2.84% | |
| FibroBiologics Files 2024 Second Quarter Report | Press release | -4.05% | -38.92% | |
| Form 10-Q FibroBiologics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.05% | -38.92% | |
| FibroBiologics Files 2024 First Quarter Report | Press release | -4.54% | -0.52% | |
| Form 10-Q FibroBiologics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.54% | -0.52% | |
| FibroBiologics Files 2023 Form 10-K Annual Report | Press release | -1.00% | -7.14% |
Keep exploring
More FBLG: analyst actions → · SEC filings → · FBLG overview →